Absolutely Sojourner! While anything is possible, you finally mention something no one has, ( I think ). Go ahead, but let's continue follow up testing
in some groups to actually see the length of efficacy. PAR mentioned 6 months to a year in between treatments, IF NEEDED. But our past history shows a much longer duration after getting treatment for a lot of folks. Don't forget that we are looking for facts required for labeling as well.
Maybe misunderstood... in our thinking.... the "longer trials" do not need to come before we start IND, but after we start.
I don't think that a CR is an issue. The story has been, at that point down the road we would almost definitely sign with a partner for sales and distribution.
Fun guessing things at times, but guessing in Pharma v FDA is waaaaayyyyyyy outta my league. I'll sit in the stands and watch the game and people watch. Of course, the best to all of the crew. Let's start the day off with some positive energy Mates!
- Forums
- ASX - By Stock
- PAR
- Ann: Trading Halt
Ann: Trading Halt, page-293
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M |
Open | High | Low | Value | Volume |
27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 17420 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.300 |
2 | 54067 | 0.295 |
2 | 6448 | 0.290 |
2 | 60208 | 0.285 |
2 | 100000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 17420 | 5 |
0.315 | 112073 | 3 |
0.320 | 120163 | 4 |
0.325 | 3050 | 2 |
0.330 | 29123 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
PAR (ASX) Chart |